Pyridazinone compounds and uses thereof
US12202819B2 · kind B2 · utility
0Cited by
16References
51Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 2023 |
| Grant date | Jan 21, 2025 |
| Priority date | — |
| Expiry date | Sep 1, 2043 |
Classification
- Technology area (CPC —)General
Abstract
Substituted pyridazinone compounds, conjugates, and pharmaceutical compositions for use in the treatment of neuromuscular diseases, such as Duchenne Muscular Dystrophy (DMD), are disclosed herein. The disclosed compounds are useful, among other things, in the treating of DMD and modulating inflammatory inhibitors IL-1, IL-6 or TNF-α.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.